AUG 11, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Clindamycin Hydrochloride (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval of labeling for an existing generic drug; no clinical efficacy or safety data presented.
Reported
Approval date2026-08-11
Dose strengths approved150 mg and 300 mg base equivalent